Correction to: Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report.

Yoshinori Arai,Maiko Ogawa,Fumitsugu Yamane,Natsuki Sumiyoshi,Rikako Arimoto,Yoshitaka Ando,Daisuke Endo,Tatsuya Nakada,Ichiro Sugawara,Hiroshi Yokoyama,Keiko Shimoyama,Hiroko Inomata,Yosuke Kawahara,Masayuki Kato,Seiji Arihiro,Atsushi Hokari,Masayuki Saruta

Correction to: Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report.

2020

Yoshinori Arai
Maiko Ogawa
Fumitsugu Yamane
Natsuki Sumiyoshi
Rikako Arimoto
Yoshitaka Ando
Daisuke Endo
Tatsuya Nakada
Ichiro Sugawara
Hiroshi Yokoyama
Keiko Shimoyama
Hiroko Inomata
Yosuke Kawahara
Masayuki Kato
Seiji Arihiro
Atsushi Hokari
Masayuki Saruta

The article "Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report", written by Yoshinori Arai, Maiko Ogawa, Fumitsugu Yamane, Natsuki Sumiyoshi, Rikako Arimoto.

Keywords:

Abdominal surgery
Hepatology
Allergy
Surgical oncology
Ulcerative colitis
Mesalazine
Medicine
Gastroenterology
Internal medicine
Colorectal surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations